Search alternatives:
significant cancer » significant concern (Expand Search), significant concerns (Expand Search), significant changes (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
cancer based » cancer care (Expand Search)
Showing 1 - 20 results of 76,365 for search '(( significant cancer based ) OR ( significant ((point decrease) OR (mean decrease)) ))', query time: 0.96s Refine Results
  1. 1
    Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR.

    Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR. by Jordan A. Gunning (18143970)

    Published 2024
    Save to List
    Saved in:
  2. 2
    Mean standard errors across time points for the outcome of social stigma.

    Mean standard errors across time points for the outcome of social stigma. by Ana Beato (20489933)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 3
    Means with standard errors across time points for the outcome of social distance.

    Means with standard errors across time points for the outcome of social distance. by Ana Beato (20489933)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 4
    Means with standard errors across time points for the outcome of intergroup anxiety.

    Means with standard errors across time points for the outcome of intergroup anxiety. by Ana Beato (20489933)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 5
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Means with standard errors across time points for the outcome of mental health knowledge.

    Means with standard errors across time points for the outcome of mental health knowledge. by Ana Beato (20489933)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 19
    Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session.

    Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. by Cristina Dolciotti (16317330)

    Published 2025
    Save to List
    Saved in:
  20. 20
    Highly suspicious variants of uncertain significance (VUS).

    Highly suspicious variants of uncertain significance (VUS). by Kimberly Gall (11372216)

    Published 2021
    Save to List
    Saved in:

Search Tools: